Beryl Drugs Closes Trading Window for Q1 FY27

Beryl Drugs Ltd has announced the closure of its trading window for all Board Members, Promoters, and Designated/Specified Connected Persons. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026. The company will intimate the date of the Board Meeting for declaring these results in due course. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct.